proadifen has been researched along with vanoxerine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baldessarini, RJ; Booth, RG; Charifson, PS; Kula, NS; McPhail, AT; Myers, AM; Owens, CE; Wyrick, SD | 1 |
| Canoll, PD; Klein, M; Musacchio, JM | 1 |
| Pai, KS; Ravindranath, V; Sriram, K | 1 |
3 other study(ies) available for proadifen and vanoxerine
| Article | Year |
|---|---|
Conformational analysis, pharmacophore identification, and comparative molecular field analysis of ligands for the neuromodulatory sigma 3 receptor.
Topics: Animals; Ligands; Models, Molecular; Molecular Conformation; Receptors, sigma; Rodentia; Structure-Activity Relationship; Tetrahydronaphthalenes | 1994 |
SKF 525-A and cytochrome P-450 ligands inhibit with high affinity the binding of [3H]dextromethorphan and sigma ligands to guinea pig brain.
Topics: Animals; Binding, Competitive; Brain; Cytochrome P-450 CYP2D6; Cytochrome P-450 Enzyme System; Debrisoquin; Dextromethorphan; Guinea Pigs; Kinetics; Ligands; Lobeline; Mixed Function Oxygenases; Neurotransmitter Uptake Inhibitors; Piperazines; Proadifen; Receptors, Opioid; Receptors, sigma; Sparteine | 1991 |
Protection and potentiation of 1-methyl-4-phenylpyridinium-induced toxicity by cytochrome P450 inhibitors and inducer may be due to the altered uptake of the toxin.
Topics: 1-Methyl-4-phenylpyridinium; Animals; Biological Transport; Brain; In Vitro Techniques; Male; Mice; Monoamine Oxidase Inhibitors; Phenobarbital; Piperazines; Piperonyl Butoxide; Proadifen | 1995 |